Skip to main content

Table 4 Comparison between study groups as regards the CPIS score after treatment (clinical cure)

From: A comparative study between effect of combined intravenous and nebulized amikacin versus intravenous amikacin alone in mechanically ventilated patients with ventilator-associated pneumonia (VAP)

CPIS Group A Group B A/B#
≤ 6 24 (75.0%) 18 (55.0%) 0.185
> 6 8 (25.0%) 14 (45.0%)
  1. #Chi-square test